SARC's Podcast SARCTalk Continues to Inform and Inspire the Sarcoma Community
ANN ARBOR, Mich., May 8, 2025 /PRNewswire/ -- The Sarcoma Alliance for Research through Collaboration (SARC) proudly celebrates the ongoing success of its groundbreaking podcast, SARCTalk. This vital platform is dedicated to advancing knowledge, raising awareness, and promoting research in the fight against sarcoma. With multiple engaging seasons, SARCTalk has become a trusted resource for patients, caregivers, researchers, and medical professionals seeking the latest insights into sarcoma diagnosis, treatment, and innovation.
SARCTalk brings together leading oncologists, researchers, patient advocates, and survivors to discuss key topics ranging from groundbreaking clinical trials and emerging therapies to the personal journeys of those affected by sarcoma. "SARCTalk plays a vital role in bridging the gap between scientific research and patient outcomes by fostering open dialogue and sharing sarcoma experts' knowledge with both lay and professional audiences," said Scott Okuno MD, originator and host of SARCTalk and Chief Medical Officer of SARC. Dr. Okuno is a medical oncologist at Mayo Clinic.
Each season of SARCTalk has expanded its impact, covering diverse topics such as:
- Cutting-edge research and clinical trials
- Patient and survivor stories of resilience
- Advances in precision medicine and immunotherapy
- The role of advocacy in driving change
- Expert guidance on treatment options and supportive care
- Mentorship and career development
"We created SARCTalk to bring the latest advancements in sarcoma research directly to those who need it most," said Steven Young, President and CEO at SARC. "The response has been incredible, and it's clear that this platform is helping to educate, empower, and connect the sarcoma community like never before."
Listeners can tune in to SARCTalk (for audio only) on Spotify & Apple Podcast and (plus video) YouTube & SARC's website https://sarctrials.org/resources/sarc-podcast. Stay connected with SARC for the latest sarcoma research and advocacy updates at https://sarctrials.org/.
About SARC
SARC (Sarcoma Alliance for Research Through Collaboration) is a US-based, non-profit public charity sarcoma research consortium solely dedicated to fostering progress in the prevention and treatment of sarcoma to improve patient outcomes and ultimately find a cure.
SARC was formed in 2003 by the sarcoma research community to bring together the best cancer centers in the world supported by centralized infrastructure for the conduct of multi-institutional collaborative sarcoma research.
SARC has successfully established itself as a leader in providing a unified platform for sarcoma experts to collaborate and fast-track more dozens of Phase I-III clinical trials (with SARC as regulatory sponsor) across close to 100 medical centers with specialized sarcoma programs in the United States and globally.
What Is Sarcoma?
Sarcomas are cancers of the bony skeleton (the skull, vertebrae, ribs, and extremities), and the so-called soft tissues, including muscle and fat. Sarcomas are disproportionately common in children and young adults but occur at all ages. There are many different types of sarcomas, leading to diagnostic and therapeutic challenges. SARC and our collaborators are working to advance the science and treatment of sarcomas.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sarcs-podcast-sarctalk-continues-to-inform-and-inspire-the-sarcoma-community-302448878.html
SOURCE SARC